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Abstract 
Background: Indolinone and spiro‑indoline derivatives have been employed in the preparation of different impor‑
tant therapeutic compounds required for treatment of anticonvulsants, antibacterial, Antitubercular, and anticancer 
activities. Schiff bases have been found to possess various pharmacological activities such as antitubercular, plant 
growth inhibiting, insecticsidal, central nerve system depressant, antibacterial, anticancer, anti‑inflammatory, and 
antimicrobial. Mannich bases have a variety of biological activities such as antibacterial and antifungal activities.
Results: In this study, a green, rapid and efficient protocol for the synthesis of a new series of Schiff bases from 
spiro[indoline‑3,4′‑pyran]‑3′‑carbonitrile derivatives using ammonium chloride as a very inexpensive and readily 
available reagent. The prepared compounds were assessed in vitro for their antimicrobial activity. Also, the cytotoxic 
activity of the prepared compounds was assessed in vitro against human cells line MCF7 breast cancer.
Conclusion: Good activity was distinguished for Schiff bases from spiro[indoline‑3,4′‑pyran]‑3′‑carbonitriles, with 
some members recorded higher antimicrobial and anti‑breast cancer activities.
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Background
The development of eco-friendly and environmentally 
benign catalytic systems is one of the main themes of 
modern organic synthesis. Ammonium chloride (NH4Cl) 
is a very inexpensive and readily available catalyst; it has 
been reported as a catalyst for the synthesis of various 
heterocyclic compounds (Shaabani et  al. 2003; Dabiri 
et al. 2009; Fortenberrya et al. 2013; Foroughifarab et al. 
2011; Maleki and Salehabadi 2010; Shaabani et al. 2008; 
Hussein 2015). There are many bioactive molecules which 
possess various heteroatoms such as nitrogen, sulfur and 
oxygen, always taken the attention of chemists over the 
years mainly because of their biological significance. 
Pyrano derivatives have well-known biological effects, 
such as analgesic and anti-inflammatory activities (El-
Zohry et  al. 2008a). Indolinone and spiro-indoline 
derivatives have possessed broad-spectrum therapeu-
tic activities such as anticonvulsants (Ragavendran et al. 
2007; Azam et al. 2009; Sridhar et al. 2002), antibacterial 
(Rahman et  al. 2004; Singh and Luntha 2009; Olomola 
and Bada 2009), Antitubercular (Sriram et al. 2005), and 
anticancer activities (Vine et  al. 2007; Solomon et  al. 
2009; Wee et al. 2009). Schiff bases are important com-
pounds owing to their wide range of biological activi-
ties and industrial applications. They have been found 
to possess various pharmacological activities such as 
antitubercular (Kascheres 2003), plant growth inhibiting 
(Simunek and Machácek 2010), insecticsidal (Shams et al. 
2011; Boyd 1988), central nerve system (CNS) depres-
sant (Drews 2000), antibacterial (Maren 1976; Supuran 
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and Scozzafava 2000), anticancer (Simunek et  al. 2007), 
anti-inflammatory, and antimicrobial (Abbate et al. 2004; 
Abdel-Mohsen and Hussein 2014). Moreover, Mannich 
bases are reported to show a variety of biological activi-
ties, such as antibacterial and antifungal activities (Sin-
gare and Ingle 1976; Huneck et  al. 1993; Hussein et  al. 
2015a). Based on these prior observations, we postulated 
that a Schiff base containing both indoline and pyran 
pharmacophores could be very effective for antimicro-
bial and anticancer activity. In this paper and as a con-
sequence of our previous work on the green synthesis of 
different spiroheterocyclic (Hussein 2013; Hussein and 
El-Khawaga 2012; Hussein 2012; El-Zohry et  al. 2008b, 
c, 2009), and bioactive heterocyclic compounds (Hus-
sein et  al. 2015b; Hussein and Abdel-Monem 2011), we 
investigated a novel green and efficient protocol that was 
developed for the synthesis of some Schiff bases (5a–l) 
by the condensation of spiro[indoline-3,4′-pyran]-3′-
carbonitrile derivatives (3a–c) with aromatic aldehydes 
(4a–d) using ammonium chloride (10 mol%) in refluxing 
ethanol as shown in Scheme 2 and Table 1. The antimi-







tives 3a–c described in this study were prepared as out-
lined in Scheme 1. The isatin Mannich bases 2a–c were 
prepared by condensing the active hydrogen atom of 
istain with formaldehyde and secondary amine namely 
diphenylamine, diethylamine, and piperidine in ethanol 
at room temperature as previously reported procedure 
(Solomon et  al. 2009). Compounds 3a–c were obtained 
in good yield via three-component condensation of 2a–c, 
malononitrile and ethyl acetoacetate in refluxed ethanol 
in presence of catalytic amount of piperidine.
Synthesis of target compounds
The Schiff bases 5a–l were obtained by the condensation of 
spiro[indoline-3,4′-pyran]-3′-carbonitrile derivatives 3a–c 
with aromatic aldehydes 4a–d using ammonium chloride 
(10 mol%) in refluxing ethanol (Scheme 2; Table 1).
To find out the suitable conditions for the reaction, a 
series of experiments were performed with the standard 
reaction of ethyl 2′-amino-3′-cyano-1-((diphenylamino)
methyl)-6′-methyl-2-oxospiro[indoline-3,4′-pyran]-5′-
carboxylate (3a), salicylaldehyde (4a) as a model reaction 
(Table 2; Scheme 3).
Effect of the reaction conditions
In our initial study, we tried to optimize the model pro-
cedure mentioned above by detecting the efficiency of 
different reaction conditions in the absence and presence 
of catalysts, such as AcOH, MeOH, EtOH, DMF/AcOH, 
EtOH/AcOH, EtOH/Et3N, EtOH/piperidine, dioxane/
NH4Cl, DMF/NH4Cl, MeOH/NH4Cl, and EtOH/NH4Cl 
(Scheme 3).
In each case, the reactants (10  mmol) were allowed 
together in 10 mL solvent at reflux temperature for 2 h. 
In the absence of catalyst, the reaction proceeded with 
comparatively lower reaction yield (Table 2, entries 1–3). 
DMF/AcOH, EtOH/AcOH, EtOH/Et3N and EtOH/
piperidine can push the reaction towards the formation 
of product in yields of 52, 61, 71, and 71 %, respectively 
(Table  2, entries 4–7). In the presence of ammonium 
chloride (NH4Cl) the reaction was possible and the prod-
uct (5a) was obtained in good yields. Ammonium chlo-
ride was used in different reaction media such as dioxane, 
DMF, methanol and ethanol (Table 2, entries 8–11). The 
best results were obtained when NH4Cl was used as cata-
lyst in ethanol as reaction medium, which provided a 
yield of 92 %.
Evaluation of catalytic activity of ammonium chloride
To determine the appropriate concentration of the cata-
lyst used, we investigated the model reaction at different 
concentrations of NH4Cl (5, 10, 15, 20, and 25  mol%). 
The product was formed in 80, 92, 92, 89, and 85 % yield, 
respectively (Table 3). This indicates that 10 mol% NH4Cl 
is sufficient to carry out the reaction smoothly.
The structures of the isolated new products 5a–l were 
deduced by analyzing their physical and spectroscopic 
Table 1 Synthesis of  the Schiff bases 5a–l using NH4Cl 
(10 mol%)
a Reaction conditions: spiro[indoline‑3,4′‑pyran]‑3′‑carbonitrile derivatives 3a–c 
(10 mmol), aromatic aldehydes 4a–d (10 mmol), and NH4Cl (10 mol%) in 10 mL 
ethanol/reflux, 2 h
b Isolated yields
Entry Producta R1, R2 R3 Yield
b (%)
1 5a (C6H5)2 2‑OH 92
2 5b (C6H5)2 4‑OCH3 82
3 5c (C6H5)2 4‑Cl 78
4 5d (C6H5)2 4‑NO2 75
5 5e (C2H5)2 2‑OH 88
6 5f (C2H5)2 4‑OCH3 84
7 5g (C2H5)2 4‑Cl 80
8 5h (C2H5)2 4‑NO2 77
9 5i 1‑Piperidinyl 2‑OH 90
10 5j 1‑Piperidinyl 4‑OCH3 86
11 5k 1‑Piperidinyl 4‑Cl 84
12 5l 1‑Piperidinyl 4‑NO2 74
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data, such as the data obtained using IR, 1H NMR, 
and 13C NMR spectroscopy. Taking 5a as an example, 
broad absorption band at 3356  cm−1 for OH group, 
sharp absorption band at 2210 cm−1 for CN group, and 
two absorption band at 1735, 1620  cm−1 for two C=O 
groups were observed in the IR spectrum with absence 
of absorption bands at 3350, 3260  cm−1 which corre-
sponding to NH2 group. The 1H NMR spectrum showed 
the presence of triplet and quartet signals at 1.28, and 
3.85 for ethyl protons, as well as, four singlet signals at 
δ = 2.28, 5.30, 8.15, and 10.38 ppm for the methyl, meth-
ylene, methane, and OH protons, respectively. In the 
13C NMR spectrum, the quaternary spiro carbon typi-
cally appeared at δ = 48.9 ppm. The nitrile and two car-




In view of biological significance, it was studied the syn-
thesized some spiro-indoline derivatives as previous, to 
get the activities of the potent compounds and evaluated 
their potential in  vitro as antibacterial, antifungal and 
antitumor activities.
Antimicrobial activities of all the synthesized Schiff 
bases 5a–l were done by cup-plate agar diffusion method. 
The compounds were prepared in DMSO and evaluated 
them for their in vitro antibacterial and antifungal activi-
ties against Bacillus subtilis and Fusarium moniliforme 
respectively. The bacterial isolate was grown on nutrient 
agar (37 °C, 24 h) the fungus was grown on potato dex-
trose agar plates (26 °C, 48–72 h). The results were noted 
Scheme 1 Synthesis of spiro[indoline‑3,4′‑pyran]‑3′‑carbonitrile derivatives 3a–c. Reagents and conditions: a Mannich reaction (HCHO and sec‑
ondary amine in ethanol, rt, 2–4 h, b malononitrile and ethyl acetoacetate in ethanol/piperidine (one drop), reflux, 5–6 h
Scheme 2 Synthesis of Schiff bases 5a–l
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by the presence of clear zone of inhibition around the 
active compounds (Table 4).
All the synthesized compounds 3a–c and 5a–l were 
tested for in  vitro antibacterial activity by inhibition 
zone method against the reference compound amoxicil-
lin (20 mm). It has been observed that all the compounds 
tested showed mild to moderate activity against tested 
bacterium but 5f, 5g and 3a. The antifungal activity of 
the compounds was studied with F. Moniliforme. The 
results are summarized in Table 4. Fluconazole has been 
used as reference for inhibitory activity (18 mm) against 
fungi and some tested compounds showed lesser activ-
ity to standard against the tested fungi. While the others 
showed no antifungal activities against the fungus.
In vitro anticancer activity
Antitumor activities were found moderate effective as 
screened for in vitro cytotoxicity activity against human 
cancer cells line MCF7 breast cancer (Table 5). Although 
the positive impact of each of the synthesized compound 
conducted toxicity in cells, some lost IC50 in the concen-
trations used. Viewing of the results, the IC50 required 
was higher than that of the reference compound (3.8 µg/
mL) used in the analysis. There are no significant differ-
ences between the results of the synthetic chemical com-
pounds compared to the reference compound, where 
statistically significant differences is the numerical value, 
and therefore all synthesized compounds located with 
reference drug in one hand.
It is worth mentioning, that the curve of the compound 
5c only showed clear a straight line. A high concentra-
tion compared to the control has shown. Theoretically an 
expectation of the IC50 may be located on the curve. Sta-
tistically the range of lethal concentrations IC50 may be 
at about 70 µg/mL, concentration that’s when kills ninety 
percent of the living cells.
Table 2 The effect of  reaction condition on  the synthesis 
of 5a
The reaction was carried out with ethyl 2′‑amino‑3′‑cyano‑1‑((diphenylamino)
methyl)‑6′‑methyl‑2‑oxospiro[indoline‑3,4′‑pyran]‑5′‑carboxylate (3a) (10 mmol) 
and 2‑hydroxybenzaldehydes (4a) (10 mmol)
a 10 mL solvent/reflux, 2 h
b 10 mol%
c Isolated yields
Entry Solventa Catalystb Yieldc (%)
1 AcOH – 47
2 MeOH – 40
3 EtOH – 44
4 DMF AcOH 52
5 EtOH AcOH 61
6 EtOH Et3N 71
7 EtOH Piperidine 71
8 Dioxane NH4Cl 73
9 DMF NH4Cl 75
10 MeOH NH4Cl 87
11 EtOH NH4Cl 92
Scheme 3 Model reaction
Table 3 Evaluation of catalytic activity of NH4Cl in the syn-
thesis of 5a
The reaction was carried out with ethyl 2′‑amino‑3′‑cyano‑1‑((diphenylamino)
methyl)‑6′‑methyl‑2‑oxospiro[indoline‑3,4′‑pyran]‑5′‑carboxylate (3a) (10 mmol) 
and 2‑hydroxybenzaldehydes (4a) (10 mmol), and NH4Cl in 10 mL ethanol at 
refluxing temperature/2 h
a Isolated yield of (5a)
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The biological activities of 3a–c and its derivatives 5a–l 
were summarized in (Fig. 1). Only cell toxicity of 3a did 
not record (>50 µg/mL) and antimicrobial activities of 5b 
and antifungal activity of 5c were not detected. The com-
pounds 3b and 5f just showed IC50 exceed 50 µg/mL but 
antimicrobial activities did not detect by 5g and 5f only. 
IC50 did not show in the tested concentrations of 5i and 
5k. Also antifungal activities did not record in 5i, 5k and 
5l as shown in (Fig. 1).
Conclusion
The authors have developed a green, rapid and efficient 
protocol for the synthesis of a new series of Schiff bases 
from spiro[indoline-3,4′-pyran]-3′-carbonitrile deriva-
tives using ammonium chloride as a very inexpensive 
and readily available reagent. The prepared compounds 
were assessed in  vitro for their antibacterial activity 
against B. subtilis as well as antifungal activity against F. 
moniliforme. Also, the cytotoxic activity of the prepared 





The IR spectra of the synthesized compounds were 
taken on a Shimazu FT spectrometer with a device of 
singly perturbed internal reflection. 1HNMR spectra (in 
DMSO-d6) were recorded on Bruker Ac-400 ultra-shield 
NMR spectrometer at 400  MHz, using TMS as internal 
standard. The 13C NMR (100 MHz) spectra were run in 
dimethylsulfoxide (DMSO-d6). Chemical shifts were 
related to that of the solvent. Mass spectra were obtained 
on a Joel JMSD-300 spectrometer operating at 70 eV. The 
elemental analysis was carried out on a perkin-Elmer C, 
H, N analyzer. Melting points were determined in open 
capillaries on a Gallenkemp melting point apparatus and 
are uncorrected.
Table 4 Biological activities of the synthesized spiro-indoline derivatives 3a–c and 5a–l




3a (C6H5)2 – >50 12 ± 2 Nill
3b (C2H5)2 – >50 24 ± 2 15 ± 2
3c Piperidinyl – 18.8 19 ± 4 2 ± 1
5a (C6H5)2 2‑OH 44.5 20 ± 2 12 ± 1
5b (C6H5)2 4‑OCH3 23.9 Nill Nill
5c (C6H5)2 4‑Cl >50 24 ± 2 10 ± 2
5d (C6H5)2 4‑NO2 25.0 18 ± 3 6 ± 1
5e (C2H5)2 2‑OH 25.0 18 ± 1 4 ± 1
5f (C2H5)2 4‑OCH3 >50 Nill Nill
5g (C2H5)2 4‑Cl 11.9 Nill Nill
5h (C2H5)2 4‑NO2 20.9 25 ± 3 10 ± 1
5i Piperidinyl 2‑OH >50 19 ± 3 Nill
5j Piperidinyl 4‑OCH3 18.8 16 ± 2 4 ± 2
5k Piperidinyl 4‑Cl >50 12 ± 1 Nill
5l Piperidinyl 4‑NO2 38.3 4 ± 1 Nill
Table 5 Cytotoxicity activity of  spiro-indoline derivatives 3a–c and  5a–l at  different concentrations (0.0, 5.0, 12.5, 25 
and 50 µg/mL) of some synthesized compounds and reference drug against human cancer cells line MCF7 breast cancer
CONC DOX 3a 5a 5b 5c 5d 3b 5e 5f 5g 5h 3c 5i 5j 5k 5l
0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
5.0 0.361 0.836 0.758 0.867 0.930 0.977 0.786 0.911 0.764 0.853 0.978 0.799 0.974 0.688 0.824 0.906
12.5 0.385 0.738 0.479 0.633 0.837 0.740 0.542 0.876 0.643 0.728 0.669 0.642 0.752 0.637 0.588 0.803
25.0 0.332 0.653 0.340 0.498 0.698 0.619 0.462 0.467 0.547 0.560 0.628 0.437 0.829 0.498 0.414 0.725
50.0 0.299 0.631 0.353 0.502 0.442 0.619 0.444 0.416 0.608 0.453 0.564 0.526 0.772 0.479 0.368 0.829
SD 0.024 0.009 0.013 0.025 0.020 0.016 0.034 0.039 0.120 0.022 0.020 0.025 0.010 0.013 0.058 0.009
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Synthesis of spiro[indoline-3,4′-pyran]-3′-carbonitrile 
derivatives 3a–c
General procedure A mixture of 1-((diphenylamino)
methyl)indoline-2,3-dione (2a) (3.28  g, 10  mmol) and 
malononitrile (0.66 g, 10 mmol) was dissolved in 20 mL 
absolute ethanol and stirred for 30 min. Then ethyl ace-
toacetate (1.30  g, 10  mmol) was added in the presence 
of piperidine (one drop) and the reaction mixture was 
heated under reflux with stirring for 6 h. Then cooled and 
the formed crystals was collected by filtration. Dried and 
recrystallized for a proper solvent.
Ethyl‑6‑amino‑5‑cyano‑1′‑((diphenylamino)methyl)‑2
‑methyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑indoline]‑3‑carbo
xylate (3a) White crystals (ethanol), yield 75  %, mp 
225–227 °C. IR (KBr): 3260, 3150 (NH2), 2185 (CN), 1724 
(C=O), 1670 (C=O). 1H NMR: δ = 1.25 (t, 3H, CH3), 2.29 
(s, 3H, CH3), 3.98–4.00 (q, 2H, CH2), 5.41 (s, 2H, CH2), 
6.80 (s, 2H, NH2, D2O-exchangeable), 6.78–7.71 (m, 14H, 
Ar–H) ppm. 13C NMR: δ = 13.6 (CH3), 18.6 (CH3), 49.0 
(C-spiro), 56.57, 60.3 (CH2), 76.7 (CH2), 100.4, 118.5 
(CN), 121.5, 121.9, 123.0, 123.4, 125.1, 128.6, 128.7, 142.1, 
151.0, 156.5, 159.2, 164.6 (C=O), 166.7 (C=O) ppm. MS: 
m/z (%) = 506.05 (M+, 45), 169.11 (100). Anal. Calcd. For 
C30H26N4O4 (506.55): C, 71.13; H, 5.17; N, 11.06. Found: 
C, 71.17; H, 5.08; N, 10.89.
Ethyl‑6‑amino‑5‑cyano‑1′‑((diethylamino)methyl)‑2‑me
thyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑indoline]‑3‑carboxylate 
(3b) As pale yellow crystals (dioxane), yield 90  %, mp 
140–142 °C. IR (KBr): 3270, 3190 (NH2), 2190 (CN), 1722 
(C=O), 1660, (C=O). 1H NMR: δ = 1.10 (t, 6H, CH3), 1.22 
(t, 3H, CH3), 1.72 (s, 3H, CH3), 2.48 (q, 4H, 2CH2), 4.18–
4.20 (q, 2H, OCH2), 4.39 (s, 2H, CH2), 6.79 (s, 2H, NH2, 
D2O-exchangeable), 6.92–7.76 (m, 4H, Ar–H) ppm. MS: 
m/z (%) =  410.19 (M+, 23), 133 (100). Anal. Calcd. For 
C22H26N4O4 (410.47): C, 64.37; H, 6.38; N, 13.65. Found: 
C, 64.42; H, 6.37; N, 13.59.
Ethyl‑6‑amino‑5‑cyano‑1′‑(piperidin‑1‑ylmethyl)‑2‑met
hyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑indoline]‑3‑carboxylate 
(3c) As pale yellow crystals (ethanol), yield 87  %, mp 
189–190 °C. IR (KBr): 3240, 3100 (NH2), 2170 (CN), 1715 
(C=O), 1665 (C=O). 1H NMR: δ  =  1.30 (t, 3H, CH3), 
1.57–1.59 (m, 6H, 3CH2), 1.74 (s, 3H, CH3), 2.60 (t, 4H, 
2CH2), 4.19–4.21 (q, 2H, CH2), 4.31 (s, 2H, CH2), 6.85 (s, 
2H, NH2, D2O-exchangeable), 6.87–7.26 (m, 4H, Ar–H) 
ppm. 13C NMR: δ =  13.9 (CH3), 14.1 (CH3), 26.0, 26.3, 
48.1 (C-spiro), 52.8 (C-pipredine), 53.9, 61.6 (CH2), 76.8 
(CH2), 106.1, 120.0 (CN), 122.9, 123.8, 126.5, 127.5, 131.2, 
138.0, 151.5, 156.2, 165.44 (C=O), 167.3 (C=O). MS: 
m/z (%) =  422.15 (M+, 23), 142 (100). Anal. Calcd. For 
C23H26N4O4 (422.48): C, 65.39; H, 6.20; N, 13.26. Found: 
C, 65.36; H, 6.18; N, 13.19.
General procedure for the synthesis of the Schiff bases 
5a–l
General procedure To a solution of spiro[indoline-3,4′-
pyran]-3′-carbonitrile derivative 3a (0.51  g, 1  mmol) in 
















Fig. 1 Biological activities of spiro‑indoline derivatives of 3a–c and 5a–l
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hyde (1 mmol) was added. Then NH4Cl (5.35 mg, 10 mol %) 
was added and the reaction mixture was refluxed for 2 h 
(monitored by TLC). After completion of the reaction, 
cold water (15–25 mL) was added to the reaction mixture. 
The solid product was filtered, washed with cold water, 
dried, and recrystallized from proper solvents.
Ethyl‑6‑(2‑hydroxybenzylidenamino)‑5‑cyano‑1′‑((diphe
nylamino)methyl)‑2methyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑in
doline]‑3‑carboxylate (5a) As yellow crystals (ethanol), 
mp 215–217 °C. IR (KBr): 3356 (br. OH), 2210 (CN), 1735 
(C=O), 1620 (C=O). 1H NMR (DMSO-d6): δ = 0.85 (t, 
3H, CH3), 2.53 (s, 3H, CH3), 3.80 (s, 2H, CH2), 3.82–3.85 
(q, 2H, CH2), 6.80–7.21 (m, 18H, Ar–H), 10.27 (s, 1H, 
OH), 10.38 (s, 1H, N=CH) ppm. 13C NMR (DMSO-d6): 
δ  =  12.9 (CH3), 18.5 (CH3), 48.9 (C-spiro), 60.2 (CH2), 
74.9 (CH2), 104.6, 111.0, 117.4 (CN), 123.3, 125.7, 127.6, 
127.9, 128.4, 129.0, 131.1, 131.6, 134.5, 142.1, 144.2, 158.4, 
158.9, 163.7 (N=CH), 164.4 (C=O), 178.5 (C=O). MS: 
m/z (%) = 610.08 (M+, 10), 262.10 (100). Anal. Calcd. For 
C37H30N4O5 (610.66): C, 72.77; H, 4.95; N, 9.17. Found: C, 
72.82; H, 4.76; N, 9.14.
Ethyl‑6‑(4‑methoxybenzylidenamino)‑5‑cyano‑1′‑((diphe
nylamino)methyl)‑2‑methyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑i
ndoline]‑3‑carboxylate (5b) As pale yellow crystals (eth-
anol), mp 212–214 °C. IR (KBr): 2180 (CN), 1740 (C=O), 
1625 (C=O). 1H NMR (DMSO-d6): δ = 0.80 (t, 3H, CH3), 
2.33 (s, 3H, CH3), 3.32 (s, 3H, OCH3), 3.81–3.83 (q, 2H, 
CH2), 3.89 (s, 2H, CH2), 6.80–7.90 (m, 18H, Ar–H), 10.38 
(s, 1H, N=CH) ppm. 13C NMR (DMSO-d6): δ  =  12.9 
(CH3), 18.5 (CH3), 48.9 (C-spiro), 55.6 (CH3), 56.6, 60.2 
(CH2), 75.4 (CH2), 104.6, 117.4 (CN), 119.3, 121.5, 122.9, 
123.8, 125.1, 127.9, 128.4, 129.1, 130.3, 131.7, 134.5, 142.1 
(C-aromatic), 158.3 (C-pyrane), 164.6 (N=CH), 169.4 
(C=O), 178.5(C=O). MS: m/z (%)  =  624.20 (M+, 13), 
252.51 (100). Anal. Calcd. For C38H32N4O5 (624.68): C, 
73.06; H, 5.16; N, 8.97. Found: C, 72.91; H, 4.90; N, 9.02.
Ethyl‑6‑(4‑chlorobenzylidenamino)‑5‑cyano‑1′‑((dipheny
lamino)methyl)‑2‑methyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑ind
oline]‑3‑carboxylate (5c) As pale brown crystals (etha-
nol), mp 230–232 °C. IR (KBr): 2180 (CN), 1742 (C=O), 
1635 (C=O). 1H NMR (DMSO-d6): δ = 0.80 (t, 3H, CH3), 
2.33 (s, 3H, CH3), 3.80 (s, 2H, CH2), 3.82–3.85 (q, 2H, 
CH2), 6.80–7.71 (m, 18H, Ar–H), 10.38 (s, 1H, N=CH) 
ppm. MS: m/z (%) = 628.61 (M+, 16), 262.11 (100). Anal. 
Calcd. For C37H29ClN4O4 (629.10): C, 70.64; H, 4.65; Cl, 
5.64; N, 8.91. Found: C, 70.75; H, 4.48; Cl, 5.50; N, 8.93.
Ethyl‑6‑(4‑nitrobenzylidenamino)‑5‑cyano‑1′‑((diphenyl
amino)methyl)‑2‑methyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑ind
oline]‑3‑carboxylate (5d) As pale yellow crystals (etha-
nol), mp 235–237 °C. IR (KBr): 2200 (CN), 1740 (C=O), 
1630 (C=O). 1H NMR (DMSO-d6): δ = 0.80 (t, 3H, CH3), 
2.30 (s, 3H, CH3), 3.32 (s, 2H, CH2), 3.81–3.83 (q, 2H, 
CH2), 6.80–8.24 (m, 18H, Ar–H), 10.37 (s, 1H, N=CH) 
ppm. 13C NMR (DMSO-d6): δ  =  12.90 (CH3), 18.46 
(CH3), 48.91 (C-spiro), 61.12 (CH2), 75.48 (CH2), 104.64, 
117.35 (CN), 118.45, 121.74, 123.35, 125.75, 127.95, 
128.52, 129.21, 131.77, 134.47, 142.00, 158.87 (C-pyrane), 
163.65 (N=CH), 166.41 (C=O), 178.45 (C=O). MS: m/z 
(%)  =  639.20 (M+, 13), 169.69 (100). Anal. Calcd. For 
C37H29N5O6 (639.66): C, 69.47; H, 4.57; N, 10.95. Found: 
C, 69.44; H, 4.48; N, 10.81.
Ethyl‑6‑(2‑hydroxybenzylidenamino)‑5‑cyano‑1′‑((diethy
lamino)methyl)‑2‑methyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑ind
oline]‑3‑carboxylate (5e) As pale yellow crystals (etha-
nol), mp 125–127 °C. IR (KBr): 3414 (br. OH), 2191 (CN), 
1724 (C=O), 1620 (C=O). 1H NMR (DMSO-d6): δ = 1.15 
(t, 6H, 2CH3), 1.24 (t, 3H, CH3), 2.27 (s, 3H, CH3), 2.39 (q, 
4H, 2CH2), 3.86 (s, 2H, CH2), 4.32–4.39 (m, 4H, 2CH2), 
6.84–7.80 (m, 8H, Ar–H), 9.85 (s, 1H, N=CH), 12.50 (s, 
1H, OH, exchangeable with D2O) ppm. 13C NMR (DMSO-
d6): δ = 13.8 (2CH3), 14.1 (CH3), 14.2 (CH3), 49.0 (C spiro), 
61.4 (2CH2), 61.6 (CH2), 67.7 (CH2), 100.2, 110.9 (CN), 
123.1, 123.4, 123.7, 124.3, 125.7, 127.7, 129.2, 130.4, 131.2, 
134.6, 140.1, 147.8, 162.2, 166.3 (N=CH), 167.3 (C=O), 
170.3 (C=O). MS: m/z (%) = 514.08 (M+, 41), 262.14 (100). 
Anal. Calcd. For C29H30N4O5 (514.57): C, 67.69; H, 5.88; N, 
10.89. Found: C, 67.42; H, 5.62; N, 11.01.
Ethyl‑6‑(4‑methoxybenzylidenamino)‑5‑cyano‑1′‑((diet
hylamino)methyl)‑2‑methyl‑2′‑oxo‑4H‑spiro[pyran‑4,3
′‑indoline]‑3‑carboxylate (5f) As pale yellow crystals 
(petroleum ether 60–80), mp 70–72  °C. IR (KBr): 2160 
(CN), 1720 (C=O), 1650 (C=O). 1H NMR (DMSO-d6): 
δ = 0.84–1.24 (m, 6H, 2CH3), 1.41 (t, 3H, CH3), 2.83 (s, 
3H, CH3), 3.86 (s, 3H, OCH3), 4.19–4.39 (m, 8H, 3CH2), 
6.85–7.83 (m, 8H, Ar–H), 9.87 (s, 1H, N=CH) ppm. MS: 
m/z (%) = 528.21 (M+, 20), 234.05 (100). Anal. Calcd. For 
C30H32N4O5 (528.60): C, 68.17; H, 6.10; N, 10.60. Found: 
C, 68.21; H, 6.01; N, 10.56.
Ethyl‑6‑(4‑chlorobenzylidenamino)‑5‑cyano‑1′‑((diethyla
mino)methyl)‑2‑methyl‑2′‑one‑4H‑spiro[pyran‑4,3′‑indol
ine]‑3‑carboxylate (5g) As pale yellow crystals (diethyl 
ether), mp 90–92 °C. IR (KBr): 2190 (CN), 1730 (C=O), 
1655 (C=O). 1H NMR (DMSO-d6): δ = 0.91–1.32 (m, 6H, 
2CH3), 1.39 (t, 3H, CH3), 2.83 (s, 3H, CH3), 4.19–4.39 (m, 
6H, 3CH2), 5.51 (s, 2H, CH2), 7.03–7.65 (m, 8H, Ar–H), 
9.88 (s, 1H, N=CH) ppm. MS: m/z (%) = 532.09 (M+, 31), 
146.00 (100). Anal. Calcd. For C29H29ClN4O4 (533.02): C, 
65.35; H, 5.48; Cl, 6.65; N, 10.51. Found: C, 65.45; H, 5.73; 
Cl, 6.61; N, 10.47.
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Ethyl‑6‑(4‑nitrobezylidenamino)‑5‑cyano‑1′‑((diethylam
ino)methyl)‑2‑methyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑indoli
ne]‑3‑carboxylate (5h) As pale yellow crystals (diethyl 
ether), m.p 85–87 °C. IR (KBr): 2170 (CN), 1724 (C=O), 
1650 (C=O). 1H NMR (DMSO-d6): δ = 0.88–1.31 (m, 6H, 
2CH3), 1.41 (t, 3H, CH3), 2.83 (s, 3H, CH3), 4.21–4.36 (m, 
6H, 3CH2), 4.38 (s, 2H, CH2), 7.12–7.85 (m, 8H, Ar–H), 
9.89 (s, 1H, N=CH) ppm. 13C NMR (DMSO-d6): δ = 13.9 
(2CH3), 14.2 (CH3), 15.1 (CH3), 49.1 (C spiro), 61.3 
(2CH2), 61.6 (CH2), 76.7 (CH2), 100.1, 117.3 (CN), 123.1, 
123.4, 123.7, 124.3, 125.7, 127.7, 129.2, 130.4, 131.2, 134.6, 
147.9, 162.2, 166.0 (N=CH), 167.3 (C=O), 170.0 (C=O). 
MS: m/z (%) = 543.01 (M+, 15), 234 (100). Anal. Calcd. 
For C29H29N5O6 (543.57): C, 64.08; H, 5.38; N, 12.88. 
Found: C, 64.04; H, 5.64; N, 12.84.
Ethyl‑6‑(2‑hydroxybenzylidenamino)‑5‑cyano‑1′‑(piperid
in‑1‑ylmethyl)‑2methyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑indo
line]‑3‑carboxylate (5i) As pale yellow crystals (diethyl 
ether), mp 110–112  °C. IR (KBr): 3455 (br. OH), 2210 
(CN), 1753 (C=O), 1634 (C=O). 1H NMR (DMSO-d6): 
δ = 090–1.13 (m, 6H, 3CH2), 1.16 (t, 3H, CH3), 2.67 (t, 4H, 
2CH2), 3.46 (s, 3H, CH3), 3.64 (s, 2H, CH2), 4.15–4.31 (q, 
2H, CH2), 6.81–7.87 (m, 8H, Ar–H), 9.96 (s, 1H, N=CH), 
10.51 (s, 1H, OH) ppm. 13C NMR (DMSO-d6): δ = 13.9 
(CH3), 14.1 (CH3), 26.2, 26.6, 52.7 (CH2-piperidine), 49.0 
(C-spiro), 53.9, 61.1, 61.6 (CH2), 76.7 (CH2), 109.2, 117.6 
(CN), 119.8, 120.1, 121.5, 123.0, 123.8, 124.6, 126.5, 131.1, 
133.7, 137.0, 140.6 (C-aromatic), 156.9, 163.5 (N=CH), 
165.4 (C=O), 167.2 (C=O). MS: m/z (%) = 526.09 (M+, 
5), 234.22 (100). Anal. Calcd. For C30H30N4O5 (526.58): C, 
68.43; H, 5.74; N, 10.64. Found: C, 68.40; H, 5.71; N, 10.36.
Ethyl‑6‑(4‑methoxybenzylidenamino)‑5‑cyano‑1′‑(piper
idin‑1‑ylmethyl)‑2‑methyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑i
ndoline]‑3‑carboxylate (5j) As brown crystals (diethyl 
ether), mp 114–117 °C. IR (KBr): 2210 (CN), 1742 (C=O), 
1631 (C=O). 1H NMR (DMSO-d6): δ = 0.90–1.13 (m, 6H, 
3CH2), 1.16 (t, 3H, CH3), 2.67 (t, 4H, 2CH2), 3.46 (s, 3H, 
CH3), 3.64 (s, 2H, CH2), 3.75 (s, 3H, OCH3), 4.15–4.30 (q, 
2H, CH2), 6.86–7.89 (m, 8H, Ar–H), 9.95 (s, 1H, N=CH) 
ppm. 13C NMR (DMSO-d6): δ = 14.0 (CH3), 14.1 (CH3), 
25.9, 26.1 (CH2), 48.4 (C-spiro), 52.1 (CH2), 53.4 (CH3), 
55.8, 61.6 (CH2), 76.8 (CH2), 106.0, 120.0 (CN), 121.1, 
122.6, 123.3, 124.8, 125.9, 126.3, 128.3, 129.7, 131.9, 156.2, 
164.3, 164.7 (N=CH), 167.5 (C=O), 169.9 (C=O). MS: 
m/z (%) =  540.20 (M+, 31), 299 (100). Anal. Calcd. For 
C31H32N4O5 (540.61): C, 68.87; H, 5.97; N, 10.36. Found: 
C, 68.63; H, 5.69; N, 10.32.
Ethyl‑6‑(4‑chlorobenzylidenamino)‑5‑cyano‑1′‑(piperidi
n‑1‑ylmethyl)‑2methyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑indol
ine]‑3‑carboxylate (5k) As pale yellow crystals (diethyl 
ether), mp 140–142 °C. IR (KBr): 2219 (CN), 1725 (C=O), 
1622 (C=O). 1H NMR (DMSO-d6): δ  =  1.13–1.17 (m, 
6H, 3CH2), 1.25 (t, 3H, CH3), 2.65 (t, 4H, 2CH2), 3.46 
(s, 3H, CH3), 3.65 (s, 2H, CH2), 4.15–4.31 (q, 2H, CH2), 
6.81–7.85 (m, 8H, Ar–H), 9.96 (s, 1H, N=CH) ppm. 13C 
NMR (DMSO-d6): δ = 14.1 (CH3), 14.2 (CH3), 26.3, 26.6 
(CH2), 49.1 (C-spiro), 53.9 (CH2), 61.3, 61.6 (CH2), 76.7 
(CH2), 106.2, 120.0 (CN), 121.5, 123.0, 124.5, 125.7, 126.5, 
128.3, 128.7, 130.9, 131.1, 134.7 (C-aromatic), 156.2, 
163.7, 165.7 (N=CH), 167.4 (C=O), 174.1 (C=O). MS: 
m/z (%)  =  544.10 (M+, 11), 261.15 (100). Anal. Calcd. 
For C30H29ClN4O4 (544.03): C, 66.11; H, 5.36; Cl, 6.50; N, 
10.28. Found: C, 66.13; H, 5.30; Cl, 6.47; N, 10.32.
Ethyl‑6‑(4‑nitrobenzylidenamino)‑5‑cyano‑1′‑(piperidi
n‑1‑ylmethyl)‑2methyl‑2′‑oxo‑4H‑spiro[pyran‑4,3′‑indo
line]‑3‑carboxylate (5l) As pale brown crystals (etha-
nol), mp 160–162 °C. IR (KBr): 2210 (CN), 1732 (C=O), 
1630 (C=O). 1H NMR (DMSO-d6): δ  =  1.15–1.17 (m, 
6H, 3CH2), 1.28 (t, 3H, CH3), 2.15 (t, 4H, 2CH2), 3.58 
(s, 3H, CH3), 4.15–4.35 (q, 2H, CH2), 5.50 (s, 2H, CH2), 
6.98–7.37 (m, 8H, Ar–H), 8.39 (s, 1H, N=CH) ppm. MS: 
m/z (%) =  555.12 (M+, 25), 205 (100). Anal. Calcd. For 
C30H29N5O6 (555.58): C, 64.85; H, 5.26; N, 12.61. Found: 
C, 64.82; H, 5.28; N, 12.59.
Biological screening
Antibacterial activity
The newly synthesized spiro-indoline derivatives 3a–c 
and 5a–l were screened for their antibacterial activity 
against bacterial isolate namely B. subtilis by inhibition 
zone method against the reference compound amoxicil-
lin (20 mm). The bacterial subcultures (18–24 h grown) 
were added to sterilize nutrient agar medium and shaken 
thoroughly to ensure uniform distribution of organism 
throughout the medium. In sterilized Petri dishes con-
taining about 20  mL of the medium, wells were made 
with a sterile cork borer and were filled with 0.1  mL of 
respective solution. Then, the Petri dishes were kept for 
incubation in an inverted position for 24–48 h at 37 °C in 
an incubator. When growth inhibition zones were devel-
oped, diameter (in mm) was measured and compared 
with that of amoxicillin.
Antifungal activity
The newly synthesized spiro-indoline derivatives 3a–c 
and 5a–l were screened for their antifungal activity 
against fungus F. moniliforme at the concentration levels 
of 50 µg/mL by inhibition zone method. Fluconazole has 
been used as reference for inhibitory activity (18  mm) 
against fungi. To the sterilized potato dextrose agar 
medium, subculture of fungus were added and shaken 
thoroughly to ensure uniform distribution and incubated 
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for 72  h. Then, this was poured into sterilized and 
labeled Petri dishes and allowed to solidify. Wells were 
made in each plate by a cork borer. Each well was filled 
with 0.1 mL of test solution and the other with respec-
tive concentrations of standard dilutions. The plates 
were left 2–3 h for diffusion and incubated at 37 °C for 
24 h. The diameter of the zones of growth inhibition was 
measured and compared with that of standard. The solu-
tions of required concentration (50 μg/mL) of test com-
pounds were prepared by dissolving the compounds in 
DMSO.
Anticancer activity
Breast cancer cell line (MCF7) as human tumor was used 
in this study. The cytotoxicity was measured in  vitro 
for the newly synthesized compounds assay using the 
method of Philip et al. (1990). The in vitro anticancer.
Screening was done by the pharmacology unit at Phar-
macology unit, Cancer biology department, the National 
Cancer Institute, Cairo University. Cells were plated in 
96-multiwell plate (104 cells/well) for 24 h before treat-
ment with the compound(s) to allow attachment of cell 
to the wall of the plate. Tested compounds were dis-
solved in dimethyl sulfoxide (DMSO). Different con-
centrations of the compound under test (0.0, 5.0, 12.5, 
25.0 and 50.0 µg/mL) were added to the cell monolayer. 
Triplicate wells were prepared for each individual con-
centration. Monolayer cells were incubated with the 
compound(s) for 48 h at 37 °C and in atmosphere of 5 % 
CO2. After 48 h. cells were fixed, washed and stained for 
30  min with 0.4  % (W/V) SRB dissolved in 1  % acetic 
acid. Excess unbound dye was removed by four washes 
with 1  % acetic acid and attached stain was recovered 
with Tris–EDTA buffer. Color intensity was measured 
in an ELISA reader. The relation between surviving frac-
tion and drug concentration is plotted to get the survival 
curve for breast tumor cell line after the specified time. 
The molar concentration required for 50 % inhibition of 
cell viability (IC50) was calculated and compared to the 
reference drug Doxorubicin (CAS, 25316-40-9). The sur-
viving fractions were expressed as means and the results 
are given in Table 5.
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